Abstract

Ankylosing spondylitis (AS) belongs to a group of diseases, called spondyloarthropathies (SpA), that are strongly associated with the genetic marker HLA-B27. AS is characterized by inflammation of joints and primarily affects the spine. Over 160 subtypes of HLA-B27 are known, owing to high polymorphism. Some are strongly associated with disease (e.g., B*2704), whereas others are not (e.g., B*2709). Misfolding of HLA-B27 molecules [as dimers, or as high-molecular-weight (HMW) oligomers] is one of several hypotheses proposed to explain the link between HLA-B27 and AS. Our group has previously established the existence of HMW species of HLA-B27 in AS patients. Still, very little is known about the mechanisms underlying differences in pathogenic outcomes of different HLA-B27 subtypes. We conducted a proteomics-based evaluation of the differential disease association of HLA B*2704 and B*2709, using stable transfectants of genes encoding the two proteins. A clear difference was observed in protein clearance mechanisms: whereas unfolded protein response (UPR), autophagy, and aggresomes were involved in the degradation of B*2704, the endosome–lysosome machinery was primarily involved in B*2709 degradation. These differences offer insights into the differential disease association of B*2704 and B*2709.

Highlights

  • Studies over the last two decades have helped to understand the link between the strong association of HLA-B27 and ankylosing spondylitis (AS)

  • Label-free quantitation of stable transfectants of H1299 cells carrying disease associated, HLA B*2704, and non-disease associated, HLA B*2709, was carried out. This was done to examine protein QC mechanisms operating in respect of the two subtypes towards clearance of protein aggregates and maintenance of cellular homeostasis

  • Considering the possibility that the aggregates in B*2704-expressing cells can possibly relieve the stress through other alternative pathways such as unfolded protein response (UPR), we examined the levels of UPR-related genes such as ATF4, BiP, and CHOP, consequent to CQ treatment; as expected, the levels of all three genes were significantly

Read more

Summary

Introduction

Studies over the last two decades have helped to understand the link between the strong association of HLA-B27 and ankylosing spondylitis (AS). It has been established that the heavy chain of HLAB27 has a tendency to misfold through the formation of either disulfide-linked dimers or oligomers/ high-molecular-weight (HMW) species [1,2,3]. Misfolded forms of HLA-B27 have been observed on cell surfaces, in the form of b2m-free homodimers. These are believed to cause pathology through binding with killer immunoglobulin-like receptors (KIRs) and leucocyte immunoglobulin-like receptors (LILRs), or through deposition within synovial tissues, resulting in activation and regulation of the immune system [5].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call